Bio Green Med Solution (BGMS) Other Non-Current Assets (2011 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Other Non-Current Assets of $224000.0 for Q1 2026, up 6.67% quarter-over-quarter from $210000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Other Non-Current Assets for 12 consecutive years, with $224000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $224000.0; the TTM figure through Mar 2026 stood at $224000.0 (changed N/A YoY), while the FY2025 annual figure was $210000.0, down 49.03% from the prior year.
- Other Non-Current Assets advanced to $224000.0 in Q1 2026 per BGMS's latest filing, from $210000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.6 million in Q2 2022 and bottomed at $210000.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $1.8 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 92.18% — and 2024, when it tumbled 73.34%.
- Bio Green Med Solution's Other Non-Current Assets stood at $3.5 million in 2022, then plunged by 62.48% to $1.3 million in 2023, then sank by 68.31% to $412000.0 in 2024, then tumbled by 49.03% to $210000.0 in 2025, then advanced by 6.67% to $224000.0 in 2026.
- Business Quant data shows BGMS's Other Non-Current Assets at $224000.0 in Q1 2026, $210000.0 in Q4 2025, and $412000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.45 Bn | 132.60 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.92 Bn | 78.93 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.47 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.28 Bn | 53.14 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.12 Bn | 35.02 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.83 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 27.93 Bn | 27.10 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Bio Green Med Solution | 5.04 Mn | 1.25 Mn | 79,000.00 | 172,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 172,000.00 |
| Mar 31, 2026 | 224,000.00 |
| Dec 31, 2025 | 210,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Sep 30, 2024 | 413,000.00 |
| Jun 30, 2024 | 413,000.00 |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 3.47 Mn |
| Dec 31, 2022 | 3.47 Mn |
| Sep 30, 2022 | 3.47 Mn |
| Jun 30, 2022 | 3.61 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 1.80 Mn |
| Sep 30, 2016 | 29,000.00 |
| Jun 30, 2016 | 75,000.00 |
| Mar 31, 2016 | 75,000.00 |